News
Dr. Naviaux receives The Vanguard Award
Dr. Robert Naviaux has been awarded the highly prestigious Vanguard Award. This remarkable accolade is the highest award bestowed in this discipline. >
Read more
United Mitochondrial Disease Foundation
UMDF Celebrates the 2023 Vanguard Award Winner Robert Naviaux, MD, PhD. >
Read more
Clinical trials of Suramin to start next year
In addition to Autism Spectrum Disorder, Suramin could be used to treat such diseases as myalgic encephalomyelitis/chronic fatigue syndrome and post-treatment Lyme disease syndrome. >
Read more
New method may predict which children will develop autism
The Naviaux lab is exploring the use of dried blood spots collected at birth. Results planned for early 2022.
Health of mitochondria connected to environmental factors
Currently three of Dr. Navaiux’s papers on this research are ranked as the top three most-downloaded scientific publications in the journal Mitochondrion. >
Read more
Suramin Autism Trial Update!
Last year, we posted about Dr. Robert Naviaux's success with the 100 year old suramin >
Read more
The UCSD Newborn Screening Autism Risk Study
Seeking Study Participants >
Read more
Lost Boys Found
At one-and-a-half years old, "Timmy" knew his colors, shapes and numbers in English, Spanish and Farsi. >
Read more
Autism Symptoms of Five Boys Improve in Early Trial of Century-old Drug
Autism symptoms improved in five boys given a century-old drug for sleeping sickness, according to a study led by UC San Diego researchers > Read more
Researchers Studying Century-Old Drug in Potential New Approach to Autism
Small, randomized clinical trial reported measurable, but transient, benefits after single dose of suramin, highlighting novel causative theory and need for more, larger and longer trial. >
Read more
Autism Trial Questions and Answers
This question and answer article about the autism clinical trial led by Rober Naviaux, professor of genetics in the departments of medicine, pediatrics and pathology of the University of California San Diego, was provided by the university. >
Read more
A Drug Used to Treat Sleeping Sickness May Also Help with Autism
It was only an initial trial, but suramin's effects were dramtic >
Read more
Stealth BioTherapeutics Reports Positive Elamipretide Data in First-Of-Its-Kind Primary Mitochondrial Myopathy Trial
Stealth BioTherapeutics (Stealth), a clinical-stage biopharmaceutical company developing investigational drugs to treat mitochondrial dysfunction, today announced the presentation of positive results from MMPOWER, >
Read more
An Eye on "The Mitochondria Man": Robert Naviaux and Chronic Fatigue Syndrome (ME/CFS)
This is the start of an "Eye On" series focusing on researchers new to the chronic fatigue syndrome/fibromyalgia research fields. Few researchers present more exciting possibilities for ME/CFS than Dr. Robert Naviaux at UC San Diego (UCSD). >
Read more
What's New in the Center for Clinical Research
Mitochondria generate most of the energy in cells throughout the body, so defects in these intracellular structures can have far-ranging, sometimes devastating, consequences. > Read more
Local Student is Mitochondrial Presenter
Del Mar resident Varun Sharma, a rising senior at the Bishop’s School had the extraordinary opportunity to be the first high school student to present his science project at a major meeting featuring mitochondrial research in June of 2011. > Read more
When Cells Stop Working
Officially, as many as 2 million Americans suffer from mitochondrial disease. But because defects in the mitochondria may underlie an astonishing range of very familiar illnesses, researchers are beginning to suspect that the real number is vastly higher. > Read more
Daughter's Death Sends Mother on Quest
Leigh's Syndrome is one of
the most deadly of all mitochondrial
diseases. It affects
areas of the brain that control
breathing, blood pressure, appetite
and coordination. > Read more